Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Cyclosporins × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 4 Myelodysplastic Syndromes 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myeloproliferative Disorders 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Biphenotypic, Acute 2 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Prolymphocytic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hemoglobinopathies 1 Burkitt Lymphoma 1 Bone Marrow Failure Disorders 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

pembrolizumab 27 Nivolumab 26 cabozantinib 25 Magnetic Resonance Spectroscopy 19 Specimen Handling 16 Ipilimumab 16 lenvatinib 10 belzutifan 7 atezolizumab 7 Biopsy 7 Axitinib 7 Sunitinib 6 Everolimus 6 CTLA-4 Antigen 6 avelumab 5 aldesleukin 5 Radiosurgery 5 Immunoglobulin G 5 Bevacizumab 5 pazopanib 4 fludarabine 4 Disulfides 4 Cyclophosphamide 4 zimberelimab 3 palbociclib 3 cemiplimab 3 Radiotherapy 3 Nephrectomy 3 IFL protocol 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡